Article
A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research - 1 Feb 2012
Ichikawa Shoji, Austin Anthony M, Gray Amie K, Econs Michael J
Abstract excerpt
Mutations in the PHEX gene cause X-linked hypophosphatemia (XLH). Hypophosphatemia in XLH results from increased circulating levels of a phosphaturic hormone, fibroblast growth factor 23 (FGF23), which inhibits renal phosphate reabsorption and 1,25-dihydroxyvitamin D (calcitriol) synthesis. The current standard therapy for XLH--high-dose phosphate and calcitriol--further increases FGF23 concentrations, suggesting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
